Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS)
CNY 63.1
(1.25%)
CNY 63.1
(1.25%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.99 Billion | 791 Million | 530.09 Million | 560.88 Thousand | 629.72 Thousand | 4.61 Million |
| Cost of Revenue | 110.01 Million | 31.71 Million | 5.64 Million | 161.69 Thousand | 270.43 Thousand | 3 Million |
| Gross Profit | 1.88 Billion | 759.28 Million | 524.44 Million | 399.19 Thousand | 359.29 Thousand | 1.61 Million |
| Operating Expenses | 1.28 Billion | 713.01 Million | 573.97 Million | 338.97 Million | 393.5 Million | 108.13 Million |
| Selling, General and Administrative Expenses | 1.03 Billion | 447.38 Million | 283.71 Million | 111.87 Million | 13.09 Million | 6.22 Million |
| Research and Development Expenses | 313.05 Million | 191.75 Million | 222.59 Million | 177.96 Million | 161.99 Million | 92.48 Million |
| Other Expenses | -113.64 Million | 73.87 Million | 67.66 Million | 49.12 Million | 218.4 Million | 868.29 Thousand |
| Cost and Expenses | 1.36 Billion | 744.73 Million | 579.61 Million | 339.13 Million | 393.77 Million | 111.14 Million |
| Operating Income | 657.66 Million | 94.64 Million | -49.52 Million | -338.57 Million | -393.14 Million | -98.26 Million |
| Interest Expense | 206.08 Thousand | 325.32 Thousand | 605.05 Thousand | 1.14 Million | 7.27 Million | 6.01 Million |
| Income Tax Expense | 12.04 Million | -4.52 Million | -44.7 Million | -7.11 Million | 2.96 Million | 6.88 Million |
| Earnings before Tax | 656.22 Million | 125.99 Million | 18.27 Million | -310.51 Million | -397.5 Million | -97.39 Million |
| Net Income | 644.17 Million | 130.52 Million | 62.97 Million | -303.39 Million | -400.47 Million | -97.39 Million |
| Earnings Per Share Basic | 1.43 | 0.29 | 0.14 | -0.67 | -0.89 | -0.27 |
| Earnings Per Share Diluted | 1.43 | 0.29 | 0.14 | -0.67 | -0.89 | -0.27 |
| Weighted Average Shares Outstanding | 450.47 Million | 450 Million | 450 Million | 450 Million | 450 Million | 361.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 450.47 Million | 450 Million | 450 Million | 450 Million | 450 Million | 361.36 Million |
| Gross Margin | 0.94 | 0.96 | 0.99 | 0.71 | 0.57 | 0.35 |
| EBIT Margin | 0.35 | 0.15 | -0.01 | -545.15 | -611.38 | -18.68 |
| Profit Margin | 0.32 | 0.17 | 0.12 | -540.93 | -635.95 | -21.08 |
| EBITDA | 696.61 Million | 153.38 Million | 44.62 Million | -296.82 Million | -380.15 Million | -86.28 Million |
| Earnings Before Tax Margin | 0.33 | 0.12 | -0.09 | -603.63 | -624.31 | -21.27 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 957 Million | 821.62 Million | 732.3 Million | 1.99 Billion | 661.3 Million | 599.12 Million |
| Cost of Revenue | 37.5 Million | 43.69 Million | 33.92 Million | 114.7 Million | 36.2 Million | 22.46 Million |
| Gross Profit | 919.49 Million | 777.92 Million | 698.38 Million | 1.87 Billion | 625.09 Million | 576.66 Million |
| Operating Expenses | 451.06 Million | 400.16 Million | 412.57 Million | 1.32 Billion | 434.13 Million | 389.65 Million |
| Selling, General and Administrative Expenses | 675.94 Million | 337.52 Million | 348.45 Million | - | 317.24 Million | 347.59 Million |
| Research and Development Expenses | 76.41 Million | 62.63 Million | 64.12 Million | - | 116.89 Million | 78.18 Million |
| Other Expenses | -301.29 Million | -1.2 Million | -19.99 Thousand | 361.63 Thousand | -376.86 Thousand | -39.82 Thousand |
| Cost and Expenses | 488.56 Million | 443.86 Million | 446.5 Million | 1.44 Billion | 470.34 Million | 412.12 Million |
| Operating Income | 486.61 Million | 377.76 Million | 285.8 Million | 549.7 Million | 190.95 Million | 207.08 Million |
| Interest Expense | 18.03 Thousand | 12.86 Thousand | 19.32 Thousand | 160.78 Thousand | 84.05 Thousand | - |
| Income Tax Expense | 72.13 Million | 48.14 Million | 7.84 Million | 12.04 Million | -4.07 Million | 5.03 Million |
| Earnings before Tax | 478.94 Million | 398.23 Million | 313.89 Million | 656.22 Million | 229.66 Million | 207.04 Million |
| Net Income | 406.81 Million | 350.08 Million | 306.05 Million | 644.17 Million | 233.74 Million | 202.01 Million |
| Earnings Per Share Basic | 0.90 | 0.78 | 0.68 | - | 0.52 | 0.45 |
| Earnings Per Share Diluted | 0.90 | 0.78 | 0.68 | - | 0.52 | 0.45 |
| Weighted Average Shares Outstanding | 450 Million | 450 Million | 450 Million | 450 Million | 450 Million | 450 Million |
| Weighted Average Shares Outstanding (Diluted) | 450 Million | 450 Million | 450 Million | 450 Million | 450 Million | 450 Million |
| Gross Margin | 0.96 | 0.95 | 0.95 | 0.94 | 0.95 | 0.96 |
| EBIT Margin | 0.50 | 0.47 | 0.43 | - | 0.30 | 0.34 |
| Profit Margin | 0.43 | 0.43 | 0.42 | 0.32 | 0.35 | 0.34 |
| EBITDA | 478.96 Million | 387.74 Million | 311.61 Million | - | 200.9 Million | 201.99 Million |
| Earnings Before Tax Margin | 0.51 | 0.46 | 0.39 | 0.28 | 0.29 | 0.35 |
ALTF
VUL
CRPHY
6538
8544
QBE